mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 148 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 2,221,754 | 0 | T | C | 50.0% | 31.4 / 15.3 | 42 | pseudogene (484/1436 nt) | mdtQ | multidrug resistance outer membrane protein MdtQ |
| * | NZ_CP009273 | 2,319,929 | 0 | T | G | 38.9% | 89.7 / 15.4 | 54 | G114G (GGT→GGG) | atoB | acetyl‑CoA acetyltransferase |
| * | NZ_CP009273 | 1,597,969 | 0 | A | T | 37.2% | 60.4 / 16.0 | 43 | I232F (ATC→TTC) | lsrC | autoinducer 2 ABC transporter permease LsrC |
| * | NZ_CP009273 | 3,199,799 | 0 | C | A | 36.2% | 109.8 / 20.2 | 70 | intergenic (‑184/‑23) | ttdR/ttdA | DNA‑binding transcriptional activator TtdR/L(+)‑tartrate dehydratase subunit alpha |
| * | NZ_CP009273 | 2,476,733 | 0 | G | A | 36.2% | 100.9 / 25.6 | 58 | S29L (TCA→TTA) | emrK | multidrug efflux MFS transporter periplasmic adaptor subunit EmrK |
| * | NZ_CP009273 | 883,470 | 0 | T | G | 36.1% | 161.8 / 16.4 | 83 | intergenic (+55/+120) | rcdA/ybjL | DNA‑binding transcriptional regulator RcdA/aspartate:alanine antiporter |
| * | NZ_CP009273 | 3,725,084 | 0 | G | A | 35.1% | 137.0 / 18.1 | 74 | L198L (TTG→TTA) | xylF | D‑xylose ABC transporter substrate‑binding protein |
| * | NZ_CP009273 | 3,806,632 | 0 | C | T | 34.9% | 56.9 / 15.9 | 44 | S181L (TCG→TTG) | coaBC | bifunctional phosphopantothenoylcysteine decarboxylase/phosphopantothenate‑‑cysteine ligase CoaBC |
| * | NZ_CP009273 | 1,560,495 | 0 | C | T | 34.7% | 118.9 / 23.1 | 72 | T301T (ACG→ACA) | dosC | diguanylate cyclase DosC |
| * | NZ_CP009273 | 3,659,062 | 0 | C | A | 34.5% | 102.6 / 14.4 | 55 | A37S (GCG→TCG) | gadX | acid resistance transcriptional activator GadX |
| * | NZ_CP009273 | 1,407,992 | 0 | A | T | 33.3% | 100.0 / 18.7 | 54 | Y2* (TAT→TAA) *65K (TAA→AAA) | rcbA ralR | double‑strand break reduction protein RcbA type I toxin‑antitoxin system endodeoxyribonuclease toxin RalR |
| * | NZ_CP009273 | 1,995,392 | 0 | G | A | 33.3% | 87.1 / 18.1 | 51 | intergenic (‑122/+199) | fliA/fliC | RNA polymerase sigma factor FliA/H48 family flagellin FliC |
| * | NZ_CP009273 | 4,431,979 | 0 | A | T | 33.3% | 146.6 / 27.8 | 81 | D5E (GAT→GAA) | msrA | peptide‑methionine (S)‑S‑oxide reductase MsrA |
| * | NZ_CP009273 | 3,725,073 | 0 | G | A | 32.9% | 120.6 / 23.7 | 74 | E195K (GAA→AAA) | xylF | D‑xylose ABC transporter substrate‑binding protein |
| * | NZ_CP009273 | 2,897,074 | 0 | G | A | 32.8% | 116.1 / 37.9 | 67 | intergenic (+341/+1032) | ygcE/queE | FGGY‑family carbohydrate kinase/7‑carboxy‑7‑deazaguanine synthase QueE |
| * | NZ_CP009273 | 339,155 | 0 | A | G | 32.8% | 110.1 / 21.5 | 65 | G187G (GGA→GGG) | yahK | NADPH‑dependent aldehyde reductase YahK |
| * | NZ_CP009273 | 1,155,293 | 0 | A | G | 32.7% | 105.2 / 12.0 | 55 | I572T (ATC→ACC) | fhuE | ferric‑rhodotorulic acid/ferric‑coprogen receptor FhuE |
| * | NZ_CP009273 | 1,408,018 | 0 | C | T | 32.7% | 108.0 / 17.9 | 55 | G56E (GGA→GAA) | ralR | type I toxin‑antitoxin system endodeoxyribonuclease toxin RalR |
| * | NZ_CP009273 | 2,372,447 | 0 | C | T | 32.7% | 71.1 / 19.8 | 56 | E98K (GAA→AAA) | menD | 2‑succinyl‑5‑enolpyruvyl‑6‑hydroxy‑3‑ cyclohexene‑1‑carboxylic‑acid synthase |
| * | NZ_CP009273 | 2,319,934 | 0 | A | G | 32.7% | 94.4 / 10.8 | 53 | E116G (GAA→GGA) | atoB | acetyl‑CoA acetyltransferase |